- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sun Pharma Advanced Research Company Ltd (SPRC)
193.92
+0.76(+0.39%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
192.39
198.60
52 wk Range
108.00
289.00
SPRC Comments
All relevant comments and discussions regarding the SPRC share are listed here. Note that all comments included here have met Investing.com India's Comment Guidelines.
double from cmp
Sparc upside 550
300 intraday if comes… i am day dreaming… pray for me…Cmp 284
Cmp 290.50
please see my previous guideline.......Excellent stock....Future is GOLD......Next target Rs 340/- TO Rs.360/-.....My personnel opinion.... Thanks to all my friend......
FUTURE IS GOOD.....? To day MKT. is variation....?
My View on SPARC: (Sun Pharma Advanced Research Ltd.)1. In June 2020 I studied the technical chart of SPARC on June 2020 and was able to arrive a bullish view on this script and found a key demand zone near 135-140 with a strong support at 130 and I bought the stock in June 1st week. My target was at 181/83 and I was trailing my stop loss at 172, I exited the trade in July 2nd week. A return of over 23% in 2 months.2. The stock took support near 157-160 to rally to 209 however this additional 29 point rally took almost 7 months.3. SPARC then started to correct and after a 2 month long consolidation, again appeared to be taking break out support near 140. I waited for Price action confirmation on my chart and then reentered near 145-147. with a SL at 137.4. My view was big bullish on the stock with a revised short term target at 287/89 with a SL at 280 by July '21 with new demand zones being added between 200-220.5. A Mid term target of 351 with a SL at 330 by November 2021 with
Common sparc 250++ advance power
233 above once again new high…
Alert set
255 target
FUTURE IS EXCELLENT........quality...and prize performance.....?please wait and watch........*
Excellent stock ....Future is GOOD.........
now base limit has stock is redy get bullish now invest highhh 🔥🔥 190 in two weeks
Lost too much in intraday!!Try our Positional calls with 95% guaranteed loss recoveryWhttssppp 8395000093(Mansi) or Tlegrm stockhousing
This share is going to Rock this season
You will never always be motivated. You have to learn to be disciplined.
BUY_______
Sun Pharma Advanced Research Company Ltd (SPRC)
____AT CURRENT MARKET PRICE FOR TARGETS ______170.6___&______172.6___.
Believe in yourself! Have faith in your abilities! Without a humble but reasonable confidence in your own powers you cannot be successful or happy
why do you treat stocks like they are some kind of motivation tool?
BUY BUY BUY BUY ______________
Sun Pharma Advanced Research Company Ltd (SPRC)
_________________ BUY BUY BUY
Teaching is the royal road to learning.
Today, buy calls by many research firms. Buy at 152 to a target of 160 SL at 147
“Life is 10% of what happens to me and 90% of how I react to it.”
Nothing should be done without a purpose.
More often than not, successful entrepreneurs are givers and not takers of positive energy.
if this stock is closed above 172 with good volume today will reach 182
any one there
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.